These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27057658)

  • 21. Thymic tumours: an update.
    Polo V; Girard N; Besse B
    Presse Med; 2013 Sep; 42(9 Pt 2):e311-6. PubMed ID: 23998928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.
    Kossai M; Duchemann B; Boutros C; Caramella C; Hollebecque A; Angevin E; Gazzah A; Bahleda R; Ileana E; Massard C; Vielh P; Soria JC; Besse B
    Lung Cancer; 2015 Sep; 89(3):306-10. PubMed ID: 26160757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MANAGEMENT OF THYMIC EPITHELIAL TUMORS].
    Paulus A; Sibille A; Bourhaba M; Martin M; Louis R; Duysinx B
    Rev Med Liege; 2015 Dec; 70(12):623-8. PubMed ID: 26867307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre.
    Crona J; Björklund P; Welin S; Kozlovacki G; Oberg K; Granberg D
    Lung Cancer; 2013 Mar; 79(3):289-93. PubMed ID: 23286964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymoma and thymic carcinoma: therapeutic approaches.
    Kurup A; Loehrer PJ
    Clin Lung Cancer; 2004 Jul; 6(1):28-32. PubMed ID: 15310414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant thymoma: current status and future directions.
    Lara PN
    Cancer Treat Rev; 2000 Apr; 26(2):127-31. PubMed ID: 10772969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of systemic therapies in the management of melanoma brain metastases.
    Lyle M; Long GV
    Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imatinib mesylate in thymic epithelial malignancies.
    Palmieri G; Marino M; Buonerba C; Federico P; Conti S; Milella M; Petillo L; Evoli A; Lalle M; Ceribelli A; Merola G; Matano E; Sioletic S; De Placido S; Di Lorenzo G; Damiano V
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):309-15. PubMed ID: 21710245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From platinum compounds to targeted therapies in advanced thoracic malignancies.
    Jakopovic M; Thomas A; Lopez-Chavez A
    Anticancer Res; 2014 Jan; 34(1):477-82. PubMed ID: 24403504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT).
    Stachowicz-Stencel T; Orbach D; Brecht I; Schneider D; Bien E; Synakiewicz A; Rod J; Ferrari A; Cecchetto G; Bisogno G
    Eur J Cancer; 2015 Nov; 51(16):2444-52. PubMed ID: 26259494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sunitinib effective for rare thymus cancer.
    Cancer Discov; 2015 Apr; 5(4):340. PubMed ID: 25680712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial and Thymic Carcinoid Tumors.
    Litvak A; Pietanza MC
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):83-102. PubMed ID: 26614370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?
    Hirai F; Toyozawa R; Nosaki K; Seto T
    J Thorac Oncol; 2016 Jan; 11(1):115-21. PubMed ID: 26762746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.
    Asao T; Fujiwara Y; Sunami K; Kitahara S; Goto Y; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Ichikawa H; Kohno T; Tsuta K; Watanabe S; Takahashi K; Ohe Y
    Lung Cancer; 2016 Mar; 93():77-81. PubMed ID: 26898618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of thymic carcinoma successfully controlled by combined chemotherapy and irradiation].
    Beppu H; Nodera H; Atarashi K; Yoshimura N; Tsukimoto K; Nagashima Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):635-9. PubMed ID: 7666619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality treatment of thymic tumors.
    Venuta F; Rendina EA; Coloni GF
    Thorac Surg Clin; 2009 Feb; 19(1):71-81. PubMed ID: 19288822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.
    Okuma Y; Hosomi Y; Takahashi S; Maeda Y; Okamura T; Hishima T
    Clin Lung Cancer; 2015 May; 16(3):221-7. PubMed ID: 25468802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
    Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
    Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.
    Liang Y; Padda SK; Riess JW; West RB; Neal JW; Wakelee HA
    Lung Cancer; 2015 Jan; 87(1):34-8. PubMed ID: 25443273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study.
    Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mankowski P
    Pediatr Blood Cancer; 2010 Jul; 54(7):916-20. PubMed ID: 20405512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.